4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-026527
EVP and COO sold 342 shares at $9.88 ($3,378)
- EVP and COO acquired 962 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Wolff Stefani · EVP and COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-30 | Exercise or conversion : show line 1 in the form | +962 | 6,455 | D | ||
| 2023-05-01 | Sale : show line 2 in the form | −342 | $9.88 | $3,378 | 6,113 | D |
| Open-market sales · 342 sh · avg $9.88 · $3,378 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −962 | 10,582 | D |
Loading xslF345X04/doc4.xml…